| abstract |
Provided is the use of calcitonin in the preparation of a medicament for the treatment of an inflammatory disease or condition. The calcitonin may be selected from the group consisting of human, salmon, eel, pig, bovine, or chicken calcitonin, or a derivative, fragment or variant thereof. Inflammatory diseases or conditions include rheumatoid arthritis (RA), juvenile rheumatoid arthritis (JRA), osteoarthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis (AS), lupus erythematosus, multiple sclerosis (MS) , Asthma, or immunosuppressive therapy (eg after transplantation surgery). Treatment may also include administration of glucocorticoids, anti-rheumatic drugs, or antibodies. |